VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Perspective Therapeutics, Inc. (CATX) Total Return Calculator with Dividends Reinvested

Perspective Therapeutics, Inc.

Popular:

The total return for Perspective Therapeutics, Inc. (CATX) stock is +53.19% over the past 12 months. So far it's up 29.03% this year. The 5-year total return is -59.00%, meaning $10,000 invested in CATX stock 5 years ago would be worth $4,100 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CATX 1 year ago, it would be worth $14,876 today — you'd have gained $4,876.

With Dividends Reinvested$14,876+48.76%

Price Only (No DRIP)$14,876+48.76%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CATX

1Y$15,319+$5,319 (+53.2%)53.2% CAGR

3Y$5,381-$4,619 (-46.2%)-18.7% CAGR

5Y$4,100-$5,900 (-59.0%)-16.3% CAGR

10Y$3,364-$6,636 (-66.4%)-10.3% CAGR

15Y$3,600-$6,400 (-64.0%)-6.6% CAGR

20Y$615-$9,385 (-93.8%)-13.0% CAGR

30Y$706-$9,294 (-92.9%)-8.5% CAGR

Perspective Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading CATX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+29.03%	—	+29.03%	—	$12,903
1Y	+53.19%	53.19%	+53.19%	—	$15,319
3Y	-46.19%	-18.66%	-46.19%	—	$5,381
5Y	-59.00%	-16.33%	-59.00%	—	$4,100
10Y	-66.36%	-10.32%	-66.36%	—	$3,364
15Y	-64.00%	-6.58%	-64.00%	—	$3,600
20Y	-93.85%	-13.01%	-93.85%	—	$615
30Y	-92.94%	-8.46%	-92.94%	—	$706

Risk & Highlights

Best Year+206.90%2009

Worst Year-91.11%2008

Max Drawdown-58.84%2025-10-15 → 2025-12-02 · Recovered 2026-02-02

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+93.55%	+93.55%	—	+0.41%	+93.1pp
2025	-16.92%	-16.92%	—	+16.64%	-33.6pp
2024	-20.45%	-20.45%	—	+24.00%	-44.4pp
2023	+64.08%	+64.08%	—	+24.81%	+39.3pp
2022	-40.34%	-40.34%	—	-19.95%	-20.4pp

CATX outperformed the S&P 500 by 22.82pp over the past year (+53.19% vs +30.37%).

Loading summary...

CATX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CATXPerspective Therapeutics, Inc.	$267M	-17.6%	+29.0%	+53.2%	—	-46.2%	-59.0%	-66.4%
AGENAgenus Inc.	$132M	-7.6%	+16.1%	+27.1%	—	-88.2%	-93.9%	-94.3%
RNWReNew Energy Global Plc	$1.3B	+13.7%	-7.8%	-17.7%	—	+4.4%	-45.7%	-50.5%
LNTHLantheus Holdings, Inc.	$5.9B	+16.5%	+35.3%	+13.1%	—	-4.0%	+314.2%	+4192.5%
NVXNovonix Limited	$150M	+4.5%	-35.8%	-39.1%	—	-74.2%	-96.9%	-96.9%
RVMDRevolution Medicines, Inc.	$30.3B	+48.0%	+80.3%	+278.4%	—	+483.1%	+382.1%	+393.1%
DVAXDynavax Technologies Corporation	$1.8B	—	+0.8%	+59.5%	—	+42.1%	+58.0%	+2.9%
NUVLNuvalent, Inc.	$7.5B	+0.1%	+1.5%	+53.5%	—	+171.2%	+446.1%	+446.1%
NVONovo Nordisk A/S	$203.5B	+24.1%	-10.2%	-29.5%	+2.8pp	-40.7%	+36.4%	+99.6%
BMYBristol-Myers Squibb Company	$114.8B	-2.5%	+7.6%	+23.4%	+5.2pp	-7.1%	+5.2%	+6.7%
NVSNovartis AG	$277.4B	-3.9%	+8.4%	+34.4%	+4.3pp	+58.5%	+94.4%	+178.5%

Compare:CATX vs AGEN CATX vs RNW CATX vs LNTH CATX vs AGEN vs RNW

About CATX Dividend Returns

Perspective Therapeutics, Inc. (CATX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CATX over the past year?

Perspective Therapeutics, Inc. (CATX) delivered a return of 53.19% over the past year. Since CATX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CATX be worth today?

A $10,000 investment in Perspective Therapeutics, Inc. one year ago would be worth $15,319 today, representing a gain of $5,319.

Q3Does CATX pay dividends?

Perspective Therapeutics, Inc. (CATX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CATX, the total return equals the price-only return.

Q4Did CATX beat the S&P 500?

Yes, Perspective Therapeutics, Inc. (CATX) outperformed the S&P 500 by 22.82 percentage points over the past year. CATX delivered a total return of 53.19%, compared to the S&P 500's 30.37%. This 22.82pp alpha means investors in CATX earned more than a passive S&P 500 index fund.

Q5What is CATX's worst drawdown?

Perspective Therapeutics, Inc. (CATX) experienced a maximum drawdown of -58.84% over the past year, declining from its peak on 2025-10-15 to its trough on 2025-12-02. The stock recovered to its prior peak by 2026-02-02. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CATX's long-term total return over 10, 20, or 30 years?

Here are Perspective Therapeutics, Inc. (CATX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -66.4% (-10.3% CAGR) — $10,000 would have grown to $3,364. Over 20 years: -93.8% total return (-13.0% CAGR) — $10,000 → $615. Over 30 years: -92.9% total return (-8.5% CAGR) — $10,000 → $706. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CATX's best and worst year?

Perspective Therapeutics, Inc.'s best calendar year was 2009 with a total return of 206.9%. Its worst year was 2008 with a total return of -91.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 298.0 percentage points.